Dhampur Bio Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on May 02, 2025.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors approved audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2025, along with an unmodified (clean) auditor opinion from Mittal Gupta & Co. Standalone revenue from operations grew about 15% YoY to Rs. 2,714.4 crore, but profit after tax fell sharply to Rs. 12.09 crore from Rs. 48.82 crore last year due to higher raw material and finance costs, plus exceptional items of Rs. 4.96 crore (insurance claim write-off and impairment of investment in subsidiary Dhampur International Pte Ltd). Consolidated PAT also declined to Rs. 14.69 crore from Rs. 46.49 crore. The Bio Fuels & Spirits segment saw major revenue and profit decline, while Country Liquor and Sugar segments performed better. The Board recommended a dividend of Rs. 1.25 per share (12.5%) with a record date of July 4, 2025, and set the AGM for July 11, 2025.
Mixed outcome for shareholders: healthy topline growth is offset by significant profit compression and weak cash returns via dividend; leadership continuity is maintained through re-appointments of Chairman, MD & CEO, and Whole Time Director. The stock may face pressure given the steep fall in earnings, though the clean audit and revenue growth provide some support.